Effect of prophylactic beta-glucan use on the incidence of neutropenic fever and survival rates in pediatric patients with sarcoma
CUKUROVA MEDICAL JOURNAL, vol.47, no.2, pp.596-602, 2022 (ESCI, TRDizin)
- Publication Type: Article / Article
- Volume: 47 Issue: 2
- Publication Date: 2022
- Doi Number: 10.17826/cumj.1039267
- Journal Name: CUKUROVA MEDICAL JOURNAL
- Journal Indexes: Emerging Sources Citation Index (ESCI), Academic Search Premier, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
- Page Numbers: pp.596-602
- Keywords: Beta-glucan, neutropenic fever, pediatric sarcomas, survival, CANCER, OSTEOSARCOMA, CHEMOTHERAPY, GUIDELINE, BLOOD
- Open Archive Collection: AVESIS Open Access Collection
- Çukurova University Affiliated: Yes
Abstract
Purpose: Some patients with cancer use herbal therapy as an adjunct while receiving conventional cancer treatments. Beta-glucans have direct cytotoxic effects on cancer cells as well as stimulatory effects on the immune system. In this study, a nutritional supplement containing 1,3-1,6 beta-glucan obtained from baker's yeast (Saccharomyces cerevisiae) was used by patients diagnosed with sarcoma, and this study aimed to retrospectively evaluate the effect of beta-glucan use on the incidence of neutropenic fever (NF) and survival rates.